Compare SOPH & SPOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOPH | SPOK |
|---|---|---|
| Founded | 2011 | 2004 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 330.4M | 268.2M |
| IPO Year | 2021 | 1992 |
| Metric | SOPH | SPOK |
|---|---|---|
| Price | $4.78 | $13.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 72.8K | ★ 165.8K |
| Earning Date | 11-04-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 9.42% |
| EPS Growth | N/A | ★ 12.68 |
| EPS | N/A | ★ 0.80 |
| Revenue | $73,297,000.00 | ★ $139,739,000.00 |
| Revenue This Year | $18.32 | $4.11 |
| Revenue Next Year | $15.61 | $2.63 |
| P/E Ratio | ★ N/A | $16.58 |
| Revenue Growth | ★ 13.66 | 1.47 |
| 52 Week Low | $2.58 | $12.26 |
| 52 Week High | $5.30 | $19.31 |
| Indicator | SOPH | SPOK |
|---|---|---|
| Relative Strength Index (RSI) | 52.71 | 50.15 |
| Support Level | $4.56 | $12.85 |
| Resistance Level | $4.84 | $13.11 |
| Average True Range (ATR) | 0.21 | 0.26 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 58.04 | 54.07 |
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.